ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

BASF invests big in ibuprofen

by Michael McCoy
July 3, 2017 | APPEARED IN VOLUME 95, ISSUE 27

BASF will spend about $225 million to increase its capacity for the bulk analgesic ibuprofen. The company says it will expand its existing facility in Bishop, Texas, next year and build a new facility by 2021 at its headquarters in Ludwigshafen, Germany. BASF says the new plant will be Europe’s first large ibuprofen facility. The firm claims to have a unique, eco-efficient manufacturing process.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment